|
1
|
American Diabetes Association, . Diagnosis
and classification of diabetes mellitus. Diabetes Care. 29:(Suppl
1). S43–S48. 2006.PubMed/NCBI
|
|
2
|
Szkudelski T, Zywert A and Szkudelska K:
Metabolic disturbances and defects in insulin secretion in rats
with streptozotocin-nicotinamide-induced diabetes. Physiol Res.
62:663–670. 2013.PubMed/NCBI
|
|
3
|
Wang H, Kouri G and Wollheim CB: ER stress
and SREBP-1 activation are implicated in β-cell glucolipotoxicity.
J Cell Sci. 118:3905–3915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: β-cell deficit and increased β-cell
apoptosis in humans with type 2 diabetes. Diabetes. 52:102–110.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weir GC, Laybutt DR, Kaneto H, Bonner-Weir
S and Sharma A: Beta-cell adaptation and decompensation during the
progression of diabetes. Diabetes. 50:(Suppl 1). S154–S159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Viollet B, Guigas B, Sanz Garcia N,
Leclerc J, Foretz M and Andreelli F: Cellular and molecular
mechanisms of metformin: An overview. Clin Sci (Lond). 122:253–270.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gunton JE, Delhanty PJ, Takahashi S and
Baxter RC: Metformin rapidly increases insulin receptor activation
in human liver and signals preferentially through insulin-receptor
substrate-2. J Clin Endocrinol Metab. 88:1323–1332. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cusi K, Consoli A and DeFronzo RA:
Metabolic effects of metformin on glucose and lactate metabolism in
noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab.
81:4059–4067. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hundal RS, Krssak M, Dufour S, Laurent D,
Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF,
Landau BR, et al: Mechanism by which metformin reduces glucose
production in type 2 diabetes. Diabetes. 49:2063–2069. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Natali A and Ferrannini E: Effects of
metformin and thiazolidinediones on suppression of hepatic glucose
production and stimulation of glucose uptake in type 2 diabetes: A
systematic review. Diabetologia. 49:434–441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gregorio F, Filipponi P, Ambrosi F,
Cristallini S, Marchetti P, Calafiore R, Navalesi R and Brunetti P:
Metformin potentiates B-cell response to high glucose: An in vitro
study on isolated perfused pancreas from normal rats. Diabete
Metab. 15:111–117. 1989.PubMed/NCBI
|
|
12
|
Marchetti P, Scharp DW, Giannarelli R,
Benzi L, Cicchetti P, Ciccarone AM, Lacy PE and Navalesi R:
Metformin potentiates glucose-stimulated insulin secretion.
Diabetes Care. 19:781–782. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lacy PE, Kostianovsky M and Louis S:
Method for the isolation of intact islets of Langerhans from the
rat pancreas. Diabetes. 16:35–39. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perfetti R, Zhou J, Doyle ME and Egan JM:
Glucagon-like peptide-1 induces cell proliferation and
pancreatic-duodenum homeobox-1 expression and increases endocrine
cell mass in the pancreas of old, glucose-intolerant rats.
Endocrinology. 141:4600–4605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Panza JL, Wagner WR, Rilo HL, Rao RH,
Beckman EJ and Russell AJ: Treatment of rat pancreatic islets with
reactive PEG. Biomaterials. 21:1155–1164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marselli L, Dotta F, Piro S, Santangelo C,
Masini M, Lupi R, Realacci M, del Guerra S, Mosca F, Boggi U, et
al: Th2 cytokines have a partial, direct protective effect on the
function and survival of isolated human islets exposed to combined
proinflammatory and Th1 cytokines. J Clin Endocrinol Metab.
86:4974–4978. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lupi R, Del Guerra S, Marselli L, Bugliani
M, Boggi U, Mosca F, Marchetti P and Del Prato S: Rosiglitazone
prevents the impairment of human islet function induced by fatty
acids: Evidence for a role of PPARgamma2 in the modulation of
insulin secretion. Am J Physiol Endocrinol Metab. 286:E560–E567.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Janjic D and Wollheim CB: Islet cell
metabolism is reflected by the MTT (tetrazolium) colorimetric
assay. Diabetologia. 35:482–485. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang ZQ, Lu FE, Leng SH, Fang XS, Chen G,
Wang ZS, Dong LP and Yan ZQ: Facilitating effects of berberine on
rat pancreatic islets through modulating hepatic nuclear factor 4
alpha expression and glucokinase activity. World J Gastroenterol.
14:6004–6011. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fernandez-Alvarez J, Conget I, Rasschaert
J, Sener A, Gomis R and Malaisse WJ: Enzymatic, metabolic and
secretory patterns in human islets of type 2
(non-insulin-dependent) diabetic patients. Diabetologia.
37:177–181. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng S, Vatamaniuk M, Huang X, Doliba N,
Lian M-M, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B,
et al: Structural and functional abnormalities in the islets
isolated from type 2 diabetic subjects. Diabetes. 53:624–632. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marchetti P, Del Guerra S, Marselli L,
Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca
F, et al: Pancreatic islets from type 2 diabetic patients have
functional defects and increased apoptosis that are ameliorated by
metformin. J Clin Endocrinol Metab. 89:5535–5541. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leclerc I, Woltersdorf WW, da Silva Xavier
G, Rowe RL, Cross SE, Korbutt GS, Rajotte RV, Smith R and Rutter
GA: Metformin, but not leptin, regulates AMP-activated protein
kinase in pancreatic islets: Impact on glucose-stimulated insulin
secretion. Am J Physiol Endocrinol Metab. 286:E1023–E1031. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin J-M, Fabregat ME, Gomis R and Bergsten
P: Pulsatile insulin release from islets isolated from three
subjects with type 2 diabetes. Diabetes. 51:988–993. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Richardson H, Campbell SC, Smith SA and
Macfarlane WM: Effects of rosiglitazone and metformin on pancreatic
beta cell gene expression. Diabetologia. 49:685–696. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kefas BA, Cai Y, Kerckhofs K, Ling Z,
Martens G, Heimberg H, Pipeleers D and Van de Casteele M:
Metformin-induced stimulation of AMP-activated protein kinase in
β-cells impairs their glucose responsiveness and can lead to
apoptosis. Biochem Pharmacol. 68:409–416. 2004. View Article : Google Scholar : PubMed/NCBI
|
